Elucidation of Melanogenesis Cascade for Identifying Pathophysiology and Therapeutic Approach of Pigmentary Disorders and Melanoma.

eumelanin hypomelanosis melanogenesis melanoma melanosome pheomelanin pigment-type switching tyrosinase tyrosinase related protein (TYRP) vesicular transport

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Aug 2020
Historique:
received: 02 08 2020
revised: 22 08 2020
accepted: 22 08 2020
entrez: 29 8 2020
pubmed: 29 8 2020
medline: 23 2 2021
Statut: epublish

Résumé

Melanogenesis is the biological and biochemical process of melanin and melanosome biosynthesis. Melanin is formed by enzymic reactions of tyrosinase family proteins that convert tyrosine to form brown-black eumelanin and yellow-red pheomelanin within melanosomal compartments in melanocytes, following the cascades of events interacting with a series of autocrine and paracrine signals. Fully melanized melanosomes are delivered to keratinocytes of the skin and hair. The symbiotic relation of a melanocyte and an associated pool of keratinocytes is called epidermal melanin unit (EMU). Microphthalmia-associated transcription factor (MITF) plays a vital role in melanocyte development and differentiation. MITF regulates expression of numerous pigmentation genes for promoting melanocyte differentiation, as well as fundamental genes for maintaining cell homeostasis. Diseases involving alterations of EMU show various forms of pigmentation phenotypes. This review introduces four major topics of melanogenesis cascade that include (1) melanocyte development and differentiation, (2) melanogenesis and intracellular trafficking for melanosome biosynthesis, (3) melanin pigmentation and pigment-type switching, and (4) development of a novel therapeutic approach for malignant melanoma by elucidation of melanogenesis cascade.

Identifiants

pubmed: 32854423
pii: ijms21176129
doi: 10.3390/ijms21176129
pmc: PMC7503925
pii:
doi:

Substances chimiques

MITF protein, human 0
Melanins 0
Microphthalmia-Associated Transcription Factor 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Health, Labour and Welfare
ID : H21-Nano-006
Organisme : Japan Society for the Promotion of Science
ID : JP20790808
Organisme : Japan Society for the Promotion of Science
ID : JP23770233

Références

Photochem Photobiol. 2008 May-Jun;84(3):582-92
pubmed: 18435614
Immunotargets Ther. 2018 Jun 07;7:35-49
pubmed: 29922629
Pigment Cell Res. 2006 Apr;19(2):154-62
pubmed: 16524431
J Dermatol Sci. 2012 Jul;67(1):51-60
pubmed: 22622238
J Invest Dermatol. 2001 Jul;117(1):81-90
pubmed: 11442753
Nature. 2006 Sep 21;443(7109):340-4
pubmed: 16988713
Biochim Biophys Acta. 1996 Aug 28;1313(2):130-8
pubmed: 8781560
J Biochem. 1999 Jan;125(1):82-9
pubmed: 9880801
Physiology (Bethesda). 2012 Apr;27(2):85-99
pubmed: 22505665
J Proteome Res. 2003 Jan-Feb;2(1):69-79
pubmed: 12643545
J Cell Biol. 1998 Aug 10;142(3):827-35
pubmed: 9700169
Nat Rev Mol Cell Biol. 2004 Jan;5(1):23-32
pubmed: 14708007
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10698-703
pubmed: 11526213
Cell. 2009 Oct 16;139(2):366-79
pubmed: 19837037
Nat Rev Mol Cell Biol. 2007 Oct;8(10):786-97
pubmed: 17878918
Hum Genet. 2015 Aug;134(8):823-35
pubmed: 25963972
J Cell Biol. 2001 Feb 19;152(4):809-24
pubmed: 11266471
J Biol Chem. 2004 May 14;279(20):21533-42
pubmed: 14976197
Cancer Sci. 2010 Sep;101(9):1939-46
pubmed: 20594194
Cell Death Dis. 2014 Feb 20;5:e1064
pubmed: 24556679
Cell Rep. 2017 Jun 13;19(11):2177-2184
pubmed: 28614705
J Invest Dermatol. 1993 Feb;100(2 Suppl):156S-161S
pubmed: 8433002
Nat Genet. 2008 Jul;40(7):835-7
pubmed: 18488028
Lab Invest. 2017 Jun;97(6):649-656
pubmed: 28263292
Nat Genet. 1994 Nov;8(3):256-63
pubmed: 7874168
J Invest Dermatol. 2008 Jan;128(1):143-50
pubmed: 17625594
Med Sci (Paris). 2011 Feb;27(2):153-62
pubmed: 21382323
Science. 2005 Feb 4;307(5710):720-4
pubmed: 15618488
J Investig Dermatol Symp Proc. 2001 Nov;6(1):105-14
pubmed: 11764278
Mol Cell Biol. 1994 Dec;14(12):8058-70
pubmed: 7969144
Genes Dev. 1998 Feb 1;12(3):316-30
pubmed: 9450927
Nature. 2020 Jan;577(7792):676-681
pubmed: 31969699
Mol Biol Cell. 2006 Aug;17(8):3598-612
pubmed: 16760433
Science. 1992 Aug 28;257(5074):1248-51
pubmed: 1325670
Pigment Cell Res. 2005 Oct;18(5):322-36
pubmed: 16162173
Nature. 1999 Mar 11;398(6723):152-6
pubmed: 10086356
J Invest Dermatol. 2009 Sep;129(9):2233-41
pubmed: 19295615
Nature. 1999 Dec 2;402(6761):496-501
pubmed: 10591209
Pigment Cell Res. 2003 Oct;16(5):523-31
pubmed: 12950732
Genet Med. 2020 Oct;22(10):1613-1622
pubmed: 32565547
J Biol Chem. 2009 Nov 13;284(46):31714-25
pubmed: 19737927
Hum Mol Genet. 2009 Dec 1;18(23):4530-45
pubmed: 19717472
Cell. 1993 Jul 30;74(2):395-404
pubmed: 8343963
Nature. 2002 Apr 25;416(6883):854-60
pubmed: 11976685
Development. 1992 Aug;115(4):1111-9
pubmed: 1280558
J Biol Chem. 1998 Dec 4;273(49):33042-7
pubmed: 9830058
Mol Biol Cell. 2005 Nov;16(11):5356-72
pubmed: 16162817
Pigment Cell Res. 2003 Aug;16(4):333-44
pubmed: 12859616
Science. 2007 Nov 30;318(5855):1418-23
pubmed: 17947548
J Invest Dermatol. 2002 Aug;119(2):475-80
pubmed: 12190873
Nature. 1998 Jan 15;391(6664):298-301
pubmed: 9440696
J Investig Dermatol Symp Proc. 1999 Sep;4(2):130-6
pubmed: 10536987
Hum Mol Genet. 2000 Nov 22;9(19):2781-8
pubmed: 11092754
Nanomedicine (Lond). 2014 Aug;9(11):1715-26
pubmed: 25321171
Pigment Cell Res. 2000 Aug;13(4):222-9
pubmed: 10952389
Nat Genet. 1998 Mar;18(3):283-6
pubmed: 9500554
Melanoma Res. 1993 Aug;3(4):263-9
pubmed: 8219759
Cell Struct Funct. 2003 Oct;28(5):431-42
pubmed: 14745135
J Biol Chem. 2008 May 2;283(18):12635-42
pubmed: 18281284
J Invest Dermatol. 2011 Nov 17;131(E1):E2-4
pubmed: 22094402
J Biomed Biotechnol. 2009;2009:457936
pubmed: 19830247
J Cell Sci. 2001 Oct;114(Pt 19):3413-8
pubmed: 11682601
Cell. 2009 Jun 12;137(6):1088-99
pubmed: 19524511
Nat Genet. 1994 Nov;8(3):251-5
pubmed: 7874167
Chem Biol. 2013 Jun 20;20(6):784-95
pubmed: 23790489
Arch Dermatol. 1991 Oct;127(10):1528-34
pubmed: 1929460
Am J Pathol. 2003 Jul;163(1):333-43
pubmed: 12819038
PLoS Biol. 2008 Sep 30;6(9):e236
pubmed: 18828673
Genetics. 2007 Jul;176(3):1679-89
pubmed: 17483404
Genes Dev. 1994 Nov 15;8(22):2770-80
pubmed: 7958932
J Dermatol. 2011 May;38(5):432-41
pubmed: 21352276
Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2448-2461
pubmed: 28259754
Mol Biol Cell. 2001 Jul;12(7):2075-85
pubmed: 11452004
Eur J Med Chem. 2018 Jul 15;155:880-888
pubmed: 29960207
Development. 2012 Jan;139(2):397-410
pubmed: 22186729
Pigment Cell Melanoma Res. 2009 Oct;22(5):623-34
pubmed: 19493315
Pigment Cell Melanoma Res. 2013 Mar;26(2):263-8
pubmed: 23253940
J Invest Dermatol. 2012 Sep;132(9):2255-62
pubmed: 22572817
J Biol Chem. 1999 Apr 30;274(18):12780-9
pubmed: 10212263
Pigment Cell Melanoma Res. 2014 Sep;27(5):699-720
pubmed: 24807163
Int J Biochem Cell Biol. 1997 Nov;29(11):1235-9
pubmed: 9451820
Endocrinology. 2005 Mar;146(3):1245-53
pubmed: 15564334
Mol Cell Biol. 1998 Feb;18(2):694-702
pubmed: 9447965
J Biol Chem. 2011 Mar 18;286(11):9321-37
pubmed: 21247888
Cell. 2007 Mar 9;128(5):853-64
pubmed: 17350573
J Invest Dermatol. 1976 Jul;67(1):72-89
pubmed: 819593
Oncol Rep. 2016 Oct;36(4):1779-86
pubmed: 27573048
FEBS Lett. 1992 Sep 14;309(3):417-20
pubmed: 1516719
Cold Spring Harb Perspect Med. 2014 May 01;4(5):
pubmed: 24789876
Biochim Biophys Acta Mol Cell Res. 2018 Jan;1865(1):76-94
pubmed: 28947386
J Biol Chem. 2000 May 12;275(19):14013-6
pubmed: 10747853
Mol Biol Cell. 2007 Mar;18(3):768-80
pubmed: 17182842
Cancer Res. 1994 May 15;54(10):2661-6
pubmed: 8168094
Cancer. 2000 Jul 15;89(2):399-403
pubmed: 10918172
Pigment Cell Melanoma Res. 2009 Oct;22(5):563-79
pubmed: 19627559
Development. 1995 Mar;121(3):731-42
pubmed: 7536655
Mol Biol Cell. 2006 Sep;17(9):4027-38
pubmed: 16837549
Nanomedicine (Lond). 2013 Jun;8(6):891-902
pubmed: 23066648
Sci Rep. 2016 Jan 27;6:19914
pubmed: 26814135
Genetics. 2001 Aug;158(4):1683-95
pubmed: 11514456

Auteurs

Tokimasa Hida (T)

Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Hokkaido, Japan.

Takafumi Kamiya (T)

Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Hokkaido, Japan.

Akinori Kawakami (A)

Cutaneous Biology Research Center, Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.

Jiro Ogino (J)

Department of Pathology, JR Sapporo Hospital, Sapporo 060-0033, Hokkaido, Japan.

Hitoshi Sohma (H)

Department of Biomedical Engineering, Sapporo Medical University School of Medicine, Sapporo 060-8556, Hokkaido, Japan.

Hisashi Uhara (H)

Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Hokkaido, Japan.

Kowichi Jimbow (K)

Institute of Dermatology & Cutaneous Sciences, Sapporo 060-0042, Hokkaido, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH